相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study
Eugenio Mercuri et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2020)
Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy
Navid Khan et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2019)
Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
Craig M. McDonald et al.
LANCET (2018)
Eukaryotic translational termination efficiency is influenced by the 3′ nucleotides within the ribosomal mRNA channel
Andrew G. Cridge et al.
NUCLEIC ACIDS RESEARCH (2018)
In Vivo Function of the Chaperonin TRiC in α-Actin Folding during Sarcomere Assembly
Joachim Berger et al.
CELL REPORTS (2018)
Off-Label Use of Ataluren in Four Non-ambulatory Patients With Nonsense Mutation Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength
Daniel Ebrahimi-Fakhari et al.
FRONTIERS IN PEDIATRICS (2018)
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Craig M. McDonald et al.
LANCET (2017)
Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data
Sean C. Taylor et al.
SCIENTIFIC REPORTS (2017)
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene
Manuel Haas et al.
NEUROMUSCULAR DISORDERS (2015)
Loss of Tropomodulin4 in the zebrafish mutant trage causes cytoplasmic rod formation and muscle weakness reminiscent of nemaline myopathy
Joachim Berger et al.
DISEASE MODELS & MECHANISMS (2014)
Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment
Mei Li et al.
FASEB JOURNAL (2014)
ATALUREN TREATMENT OF PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY
Katharine Bushby et al.
MUSCLE & NERVE (2014)
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice
Nicolas Wein et al.
NATURE MEDICINE (2014)
503unc, a small and muscle-specific zebrafish promoter
Joachim Berger et al.
GENESIS (2013)
Knockdown of desmin in zebrafish larvae affects interfilament spacing and mechanical properties of skeletal muscle
Mei Li et al.
JOURNAL OF GENERAL PHYSIOLOGY (2013)
Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
Richard S. Finkel et al.
PLOS ONE (2013)
Quantification of birefringence readily measures the level of muscle damage in zebrafish
Joachim Berger et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy
James J. Dowling et al.
BRAIN (2012)
Suppression of premature termination codons as a therapeutic approach
Kim M. Keeling et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Nonsense Mutation-Associated Becker Muscular Dystrophy: Interplay Between Exon Definition and Splicing Regulatory Elements within the DMD Gene
Kevin M. Flanigan et al.
HUMAN MUTATION (2011)
Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafish
Joachim Berger et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view
Jose M. Lopez-Novoa et al.
KIDNEY INTERNATIONAL (2011)
Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD
Christophe Pichavant et al.
MOLECULAR THERAPY (2011)
Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology
Joachim Berger et al.
NEUROMUSCULAR DISORDERS (2010)
Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124
Douglas S. Auld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The zebrafish dystrophic mutant softy maintains muscle fibre viability despite basement membrane rupture and muscle detachment
Arie S. Jacoby et al.
DEVELOPMENT (2009)
DMD Exon 1 Truncating Point Mutations: Amelioration of Phenotype by Alternative Translation Initiation in Exon 6
Olga L. Gurvich et al.
HUMAN MUTATION (2009)
Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression
Douglas S. Auld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structure and function of skeletal muscle in zebrafish early larvae
Ying Dou et al.
JOURNAL OF GENERAL PHYSIOLOGY (2008)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Early nonsense: mRNA decay solves a translational problem
Nadia Amrani et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo
DI Bassett et al.
DEVELOPMENT (2003)
Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family
IB Ginjaar et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
